FRUZAQLA
Identification of Fruzaqla
No description |
Google image searchProduct monograph
Active ingredient
fruquintinib, 1 MG
DIN: 02551454
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: TAKEDA CANADA INC
Date: 30-OCT-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EK — Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EK04 — FRUQUINTINIB (ATC/DDD)
Reference brand drug: Fruzaqla
External Links for Fruzaqla
Search on Google
Takeda Canada Inc
Go to Takeda website to see drug product details. Sometimes you can find fruzaqla photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.